Search - tctmd.com

Displaying 1 - 20 of 236

Sort: Relevancy | Date

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Presentation ARCH 2022

Top Vascular Trials of the Past Three Years

Presenter: Sahil A. Parikh

April 23, 2022

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

Presentation Fellows 2019

Pulmonary Embolism and Venous Disease: The Next Frontier of Endovascular Intervention?

Presenter: William Gray

April 14, 2019

Presentation LINC 2019

What Are the Current Recommendations for “Optimal Medical Therapy”

Presenter: Daniella Kadian-Dodov

January 25, 2019

Presentation LINC 2019

How I Do It: Venous Stenting for Chronic Venous Obstruction (CVO)

Presenter: Angela A. Kokkosis

January 25, 2019

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presentation ESC 2018

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

Presentation ISET 2018

DVT and PE Interventions: Case-Based Discussion with the Experts

Presenter: Brian J. Schiro

February 04, 2018

Presentation ISET 2018

Arteriovenous Malformations: Evaluation to Treatment

Presenter: Paul Rochon

February 04, 2018

Presentation ISET 2018

Pulmonary Arteriovenous Malformations: How to Approach and When to Treat

Presenter: Scott Trerotola

February 03, 2018

Presentation iASSESS 2017

Aspirin and ADP Antagonists Pre and Post Coronary Stent Implantation

Presenter: Dmitriy N. Feldman

August 30, 2017

Presentation iASSESS 2017

iASSESS: Intervention for Venous Disease

Presenter: Vishal Kapur

August 30, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation ISET 2017

IVC Filters in the Setting of PE: Who and When?

Presenter: Akhilesh Sista

February 04, 2017

Presentation ISET 2017

Anticoagulation Following DVT: Agents and Length of Treatment

Presenter: Ian del Conde

February 04, 2017

Presentation ISET 2017

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Presenter: William T. Kuo

February 04, 2017

Presentation

Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism (PE)

Presenter: Behnood Bikdeli

February 28, 2016

Presentation ISET 2016

The First Visit Evaluation of a Patient with Superficial Venous Disease

Presenter: Raghu Kolluri

February 05, 2016

Presentation Aortovascular 2015

Which Patients Should Get IVC Filters? And what kind?

Presenter: Nicholas J. Morrissey

September 18, 2015

Presentation Aortovascular 2015

The Evolving Role of Endovascular Treatment for DVT

Presenter: Nicholas J. Morrissey

September 18, 2015

Advertisement

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Top Vascular Trials of the Past Three Years

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Pulmonary Embolism and Venous Disease: The Next Frontier of Endovascular Intervention?

What Are the Current Recommendations for “Optimal Medical Therapy”

How I Do It: Venous Stenting for Chronic Venous Obstruction (CVO)

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

DVT and PE Interventions: Case-Based Discussion with the Experts

Arteriovenous Malformations: Evaluation to Treatment

Pulmonary Arteriovenous Malformations: How to Approach and When to Treat

Aspirin and ADP Antagonists Pre and Post Coronary Stent Implantation

iASSESS: Intervention for Venous Disease

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

IVC Filters in the Setting of PE: Who and When?

Anticoagulation Following DVT: Agents and Length of Treatment

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism (PE)

The First Visit Evaluation of a Patient with Superficial Venous Disease

Which Patients Should Get IVC Filters? And what kind?

The Evolving Role of Endovascular Treatment for DVT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content